{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T11:17:25Z","timestamp":1777547845229,"version":"3.51.4"},"reference-count":58,"publisher":"SAGE Publications","issue":"1","license":[{"start":{"date-parts":[[2006,4,1]],"date-time":"2006-04-01T00:00:00Z","timestamp":1143849600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Adv Dent Res."],"published-print":{"date-parts":[[2006,4]]},"abstract":"<jats:p>Highly active anti-retroviral therapy (HAART) has revolutionized the treatment and prognosis of HIV disease and AIDS in those who can take advantage of the treatment. There are currently 20 different anti-retroviral drugs in 4 different classes that are used in specific combinations. Suppression of HIV replication and immune reconstitution are goals of therapy. Since the prevalence of some easily detectable oral manifestations of HIV\/AIDS (OMHIV\/AIDS) decreases with HAART, it has been suggested that they might be clinically useful surrogate markers of HAART efficacy and immune status. This might be particularly useful if their recurrence presaged or accompanied HAART failure. To date, there has been little work in this area, but its potential value to the clinical management of HIV\/AIDS is apparent, especially if frequent measures of viral load and CD4 cell counts are not readily available. However, the usefulness of OMHIV\/AIDS as signals for HAART failure is complicated by three phenomena: the immune reconstitution syndrome, the similarity of some adverse reactions of HAART to OMHIV\/AIDS, and the direct inhibitory effect of HAART medications on some OMHIV\/AIDS ( e.g., inhibition of oral candidosis by protease inhibitors). This workshop considered the current evidence and proposed pertinent research questions.<\/jats:p>","DOI":"10.1177\/154407370601900126","type":"journal-article","created":{"date-parts":[[2009,1,8]],"date-time":"2009-01-08T19:41:28Z","timestamp":1231443688000},"page":"146-151","source":"Crossref","is-referenced-by-count":35,"title":["(B3) Markers of Immunodeficiency and Mechanisms of HAART Therapy on Oral Lesions"],"prefix":"10.1177","volume":"19","author":[{"given":"S.R.","family":"Flint","sequence":"first","affiliation":[{"name":"Department of Oral and Maxillofacial Surgery, Oral Medicine and Oral Pathology, Dublin Dental School and Hospital, Trinity College Dublin, Lincoln Place, Dublin 2, Ireland"},{"name":"Guy\u2019s, King\u2019s and St Thomas\u2019 Dental Institute, Department of Oral Medicine and Pathology, Guy\u2019s Hospital, London, UK"},{"name":"Louisiana State University Health Science Center, School of Dentistry, New Orleans, USA"},{"name":"Charit\u00e9 Zahn\u00e4artzliche R\u00f6ntgenologie, Berlin, Germany; and"},{"name":"Department of Oral and Maxillofacial Pathology, Medicine and Surgery, Temple University School of Dentistry, Philadelphia, PA, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Tappuni","sequence":"additional","affiliation":[{"name":"Department of Oral and Maxillofacial Surgery, Oral Medicine and Oral Pathology, Dublin Dental School and Hospital, Trinity College Dublin, Lincoln Place, Dublin 2, Ireland"},{"name":"Guy\u2019s, King\u2019s and St Thomas\u2019 Dental Institute, Department of Oral Medicine and Pathology, Guy\u2019s Hospital, London, UK"},{"name":"Louisiana State University Health Science Center, School of Dentistry, New Orleans, USA"},{"name":"Charit\u00e9 Zahn\u00e4artzliche R\u00f6ntgenologie, Berlin, Germany; and"},{"name":"Department of Oral and Maxillofacial Pathology, Medicine and Surgery, Temple University School of Dentistry, Philadelphia, PA, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Leigh","sequence":"additional","affiliation":[{"name":"Department of Oral and Maxillofacial Surgery, Oral Medicine and Oral Pathology, Dublin Dental School and Hospital, Trinity College Dublin, Lincoln Place, Dublin 2, Ireland"},{"name":"Guy\u2019s, King\u2019s and St Thomas\u2019 Dental Institute, Department of Oral Medicine and Pathology, Guy\u2019s Hospital, London, UK"},{"name":"Louisiana State University Health Science Center, School of Dentistry, New Orleans, USA"},{"name":"Charit\u00e9 Zahn\u00e4artzliche R\u00f6ntgenologie, Berlin, Germany; and"},{"name":"Department of Oral and Maxillofacial Pathology, Medicine and Surgery, Temple University School of Dentistry, Philadelphia, PA, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.-M.","family":"Schmidt-Westhausen","sequence":"additional","affiliation":[{"name":"Department of Oral and Maxillofacial Surgery, Oral Medicine and Oral Pathology, Dublin Dental School and Hospital, Trinity College Dublin, Lincoln Place, Dublin 2, Ireland"},{"name":"Guy\u2019s, King\u2019s and St Thomas\u2019 Dental Institute, Department of Oral Medicine and Pathology, Guy\u2019s Hospital, London, UK"},{"name":"Louisiana State University Health Science Center, School of Dentistry, New Orleans, USA"},{"name":"Charit\u00e9 Zahn\u00e4artzliche R\u00f6ntgenologie, Berlin, Germany; and"},{"name":"Department of Oral and Maxillofacial Pathology, Medicine and Surgery, Temple University School of Dentistry, Philadelphia, PA, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"MacPhail","sequence":"additional","affiliation":[{"name":"Department of Oral and Maxillofacial Surgery, Oral Medicine and Oral Pathology, Dublin Dental School and Hospital, Trinity College Dublin, Lincoln Place, Dublin 2, Ireland"},{"name":"Guy\u2019s, King\u2019s and St Thomas\u2019 Dental Institute, Department of Oral Medicine and Pathology, Guy\u2019s Hospital, London, UK"},{"name":"Louisiana State University Health Science Center, School of Dentistry, New Orleans, USA"},{"name":"Charit\u00e9 Zahn\u00e4artzliche R\u00f6ntgenologie, Berlin, Germany; and"},{"name":"Department of Oral and Maxillofacial Pathology, Medicine and Surgery, Temple University School of Dentistry, Philadelphia, PA, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"179","published-online":{"date-parts":[[2006,4,1]]},"reference":[{"key":"ALLAN-ETAL-1993","doi-asserted-by":"publisher","DOI":"10.1093\/clinids\/16.Supplement_1.S46"},{"key":"CALISTA-AND-BOSCHINI-2000","unstructured":"Calista D, Boschini A (2000). Cutaneous side effects induced by indinavir. Eur J Dermatol 10:292\u2013296."},{"key":"CAMPO-ETAL-2002","doi-asserted-by":"publisher","DOI":"10.1034\/j.1600-0714.2002.310102.x"},{"key":"CASSONE-ETAL-2002","doi-asserted-by":"publisher","DOI":"10.1086\/338445"},{"key":"CAUDA-ETAL-1999","doi-asserted-by":"publisher","DOI":"10.1097\/00126334-199905010-00003"},{"key":"CEBALLOS-SALOBRENA-ETAL-2000","doi-asserted-by":"publisher","DOI":"10.1089\/10872910050206540"},{"key":"CUTLER-AND-IACOPINO-2003","unstructured":"Cutler CW, Iacopino AM (2003). Periodontal disease: links with serum lipid\/triglyceride levels? Review and new data. J Int Acad Periodontol 5:47\u201351."},{"key":"DANNER-ETAL-1995","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199512073332303"},{"key":"EC-CLEARINGHOUSE-1993","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0714.1993.tb01074.x"},{"key":"EYESON-ETAL-2002","doi-asserted-by":"publisher","DOI":"10.1034\/j.1600-0714.2002.310308.x"},{"key":"FAGOT-ETAL-2001","doi-asserted-by":"publisher","DOI":"10.1097\/00002030-200109280-00014"},{"key":"FLANAGAN-ETAL-2000","unstructured":"Flanagan MA, Barasch A, Koenigsberg SR, Fine D, Houpt M (2000). Prevalence of oral soft tissue lesions in HIV-infected minority children treated with highly active antiretroviral therapies. Pediatr Dent 22:287\u2013291."},{"key":"FRENCH-1999","unstructured":"French MA (1999). Antiretroviral therapy. Immune restoration disease in HIV-infected patients on HAART. AIDS Read 9:548\u2013562."},{"key":"GALLANT-ETAL-2003","unstructured":"Gallant JE, Rodriguez A, Weinberg W (2003). Early non-response to tenofovir, abacavir and lamivudine in a randomized controlled trial compared to efavirenz, abacavir and lamivudine (abstract). Presented at the 43rd Interscience Conference on Antimicrobial Agents and Chemotherapy. Chicago, IL."},{"key":"GOROCHOV-ETAL-1998","doi-asserted-by":"publisher","DOI":"10.1038\/nm0298-215"},{"key":"GREENBERG-AND-BERGER-1990","doi-asserted-by":"publisher","DOI":"10.1016\/0190-9622(90)70039-K"},{"key":"GREENSPAN-ETAL-2001","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(00)04578-5"},{"key":"GREENSPAN-ETAL-2004","doi-asserted-by":"publisher","DOI":"10.1177\/154405910408300212"},{"key":"GREENSPAN-ETAL-1992","doi-asserted-by":"publisher","DOI":"10.1016\/0030-4220(92)90185-S"},{"key":"GREENWOOD-ETAL-2002","doi-asserted-by":"publisher","DOI":"10.1034\/j.1601-0825.2002.1o787.x"},{"key":"HO-1995","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199508173330710"},{"key":"KERDPON-ETAL-2004","doi-asserted-by":"publisher","DOI":"10.1046\/j.1601-0825.2003.00990.x"},{"key":"KHONGKUNTHIAN-ETAL-2001","doi-asserted-by":"publisher","DOI":"10.1034\/j.1600-0714.2001.300907.x"},{"key":"KUNIMOTO-ETAL-1999","unstructured":"Kunimoto DY, Chiu L, Nobert E, Houston S (1999). Immune mediated \u2018HAART\u2019 attack during treatment for tuberculosis. Highly active antiretroviral therapy. Int J Tuberc Lung Dis 3:944\u2013947."},{"key":"MADEDDU-ETAL-2004","unstructured":"Madeddu G, Spanu A, Solinas P, Calia GM, Lovigu C, Chessa F,\n                      et al.\n                      (2004). Bone mass loss and vitamin D metabolism impairment in HIV patients receiving highly active antiretroviral therapy. Q J Nucl Med Mol Imaging 48:39\u201348."},{"key":"MANFREDI-2004","doi-asserted-by":"publisher","DOI":"10.1016\/j.arr.2003.07.001"},{"key":"MANFREDI-ETAL-2003A","unstructured":"Manfredi R, Calza L, Chiodo F (2003a). Multiple AIDS-related malignancies just in the era of potent antiretroviral therapy. A rare but intriguing finding. Infez Med 11:153\u2013156."},{"key":"MANFREDI-ETAL-2003B","doi-asserted-by":"publisher","DOI":"10.1258\/095646203322301130"},{"key":"MARGIOTTA-ETAL-1999","doi-asserted-by":"crossref","unstructured":"Margiotta V, Campisi G, Mancuso S, Accurso V, Abbadessa V (1999). HIV infection: oral lesions, CD4+ cell count and viral load in an Italian study population. J Oral Pathol Med 28:173\u2013177.","DOI":"10.1111\/j.1600-0714.1999.tb02019.x"},{"key":"MCNEELY-ETAL-1989","doi-asserted-by":"publisher","DOI":"10.1016\/S0190-9622(89)70332-7"},{"key":"MUNRO-AND-HUBE-2002","doi-asserted-by":"publisher","DOI":"10.1016\/S0966-842X(02)02330-2"},{"key":"NICOLATOU-GALITIS-ETAL-2004","doi-asserted-by":"publisher","DOI":"10.1046\/j.1601-0825.2003.00994.x"},{"key":"NIELSEN-ETAL-1994","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0714.1994.tb01102.x"},{"key":"NOTERMANS-ETAL-1999","doi-asserted-by":"publisher","DOI":"10.1086\/315013"},{"key":"OKUNSERI-ETAL-2003","doi-asserted-by":"publisher","DOI":"10.1089\/108729103321042863"},{"key":"OLIVE-ETAL-1998","doi-asserted-by":"crossref","unstructured":"Olive A, Salavert A, Manriquez M, Clotet B, Moragas A (1998). Parotid lipomatosis in HIV positive patients: a new clinical disorder associated with protease inhibitors [letter\/case report]. Ann Rheum Dis 57:749.","DOI":"10.1136\/ard.57.12.749"},{"key":"PAKKER-ETAL-1997","doi-asserted-by":"publisher","DOI":"10.1097\/00042560-199712150-00002"},{"key":"PAKKER-ETAL-1998","doi-asserted-by":"publisher","DOI":"10.1038\/nm0298-208"},{"key":"PATEL-AND-MANDEL-2001","unstructured":"Patel S, Mandel L (2001). Parotid gland swelling in HIV diffuse infiltrative CD8 lymphocytosis syndrome. NY State Dent J 67:22\u201323."},{"key":"PATTON-ETAL-2000","doi-asserted-by":"publisher","DOI":"10.1016\/S1079-2104(00)70092-8"},{"key":"POIZOT-MARTIN-ETAL-1991","unstructured":"Poizot-Martin I, Lafeuillade A, Dhiver C, Xeri L, Bouabdallah R, Gamby T,\n                      et al.\n                      (1991). Cutaneo-mucosal hyperpigmentation in AIDS. 4 cases. Presse Med 20:632\u2013636."},{"key":"PONGSIRIWET-ETAL-2003","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-263X.2003.00448.x"},{"key":"RAMIREZ-AMADOR-ETAL-2003","doi-asserted-by":"publisher","DOI":"10.1097\/00005792-200301000-00004"},{"key":"RENVERT-2003","unstructured":"Renvert S (2003). Destructive periodontal disease in relation to diabetes mellitus, cardiovascular diseases, osteoporosis and respiratory diseases. Oral Health Prev Dent 1(Suppl 1):341\u2013357; discussion 358\u2013359."},{"key":"ROEDERER-1998","doi-asserted-by":"publisher","DOI":"10.1038\/nm0298-145"},{"key":"RUANE-AND-DEJESUS-2004","doi-asserted-by":"publisher","DOI":"10.1097\/01.qai.0000137003.25258.76"},{"key":"SCHIFFMAN-ETAL-1999","doi-asserted-by":"publisher","DOI":"10.1016\/S0899-9007(99)00152-5"},{"key":"SCHMIDT-WESTHAUSEN-ETAL-2000","doi-asserted-by":"publisher","DOI":"10.1034\/j.1600-0714.2000.290708.x"},{"key":"SCULLY-ETAL-2001","doi-asserted-by":"publisher","DOI":"10.1034\/j.1601-0825.2001.70401.x"},{"key":"SHIBOSKI-ETAL-1996","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.1996.00440180113014"},{"key":"SKOLASKY-ETAL-2001","doi-asserted-by":"publisher","DOI":"10.1089\/08892220152596551"},{"key":"TAPPUNI-AND-FLEMING-2001","doi-asserted-by":"publisher","DOI":"10.1067\/moe.2001.118902"},{"key":"THOMAS-AND-DOHERTY-2003","doi-asserted-by":"publisher","DOI":"10.1097\/00126334-200307010-00001"},{"key":"US-DEPARTMENT-OF-HEALTH-AND-HUMAN-SERVICES-2005","unstructured":"US Department of Health and Human Services and Henry J. Kaiser Family Foundation (2005). Guidelines for the use of antiretroviral agents in HIV-1-infected adults and adolescents. http:\/\/AIDSinfo.nih.gov\/ContentFiles\/AdultandAdolescentGL.pdf."},{"key":"WETTERWALD-ETAL-1999","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2133.1999.02850.x"},{"key":"WORKING-GROUP-2005","unstructured":"Working group on antiretroviral therapy and medical management of HIV-infected children, National Resource Centre, UMDNJ, the Health Resources and Services Administration, National Institutes of Health (2005). http:\/\/AIDSinfo.nih.gov."},{"key":"YOSHIHARA-ETAL-2004","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-051X.2004.00548.x"},{"key":"ZINGMAN-1996","doi-asserted-by":"crossref","unstructured":"Zingman BS (1996). Resolution of refractory AIDS-related mucosal candidiasis after initiation of didanosine plus saquinavir [case report\/letter]. N Engl J Med 334:1674\u20131675.","DOI":"10.1056\/NEJM199606203342516"}],"container-title":["Advances in Dental Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/154407370601900126","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/154407370601900126","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/154407370601900126","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T17:42:24Z","timestamp":1777398144000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/154407370601900126"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,4]]},"references-count":58,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2006,4]]}},"alternative-id":["10.1177\/154407370601900126"],"URL":"https:\/\/doi.org\/10.1177\/154407370601900126","relation":{},"ISSN":["0895-9374","1544-0737"],"issn-type":[{"value":"0895-9374","type":"print"},{"value":"1544-0737","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,4]]}}}